The Central Bank of Iran has announced that foreign currency allocations for importing medicines, pharmaceutical raw materials, and medical equipment have exceeded $1.04 billion, supplied through both preferential and non-preferential exchange rates.
According to the approved quarterly budget, a total of $800 million in preferential currency and $400 million in non-preferential currency was planned for the first quarter of the year. Despite delays in preferential funding by related agencies, the Central Bank — under the directive of its Governor and in recognition of the critical importance of public health — successfully provided over $525 million in preferential and $520 million in non-preferential currency by June 7 (18 Khordad).
This total surpasses the original target, reflecting the government’s commitment to maintaining the flow of essential medical supplies and treatments.
